Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review
- 1 March 2018
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 24 (2), 186-197
- https://doi.org/10.1111/hae.13424
Abstract
Inhibitors are antibodies directed against haemophilia treatment products which interfere with their function. Factor VIII (FVIII) inhibitors in haemophilia A and factor IX (FIX) inhibitors in haemophilia B are significant clinically when they require a change in a patient's treatment regimen. Their persistence may increase morbidity and mortality. Multiple laboratory tests are now available for detecting and understanding inhibitors in haemophilia. Inhibitors are traditionally measured by their interference in clotting or chromogenic factor assays. They may also be detected using immunologic assays, such as enzyme-linked immunosorbent assay or fluorescence immunoassay. Anti-FVIII or anti-FIX antibodies of IgG(4) subclass best correlate with the presence of functional inhibitors. Improvements in inhibitor measurement have been recently introduced. Preanalytical heat treatment of patient specimens allows testing of patients without delaying treatment. Use of chromogenic and immunologic assays may aid in identification of false-positive results, which are frequent among low-titre inhibitors. Validated reagent substitutions can be used to reduce assay cost. New methods for defining assay positivity and reporting low-titre inhibitors have been suggested. Challenges remain in the areas of quality control, assay standardization, monitoring of patients undergoing immune tolerance induction therapy and testing in the presence of modified and novel treatment products.Keywords
This publication has 111 references indexed in Scilit:
- Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon ResonancePLOS ONE, 2013
- Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patientsBlood, 2013
- Low‐titre inhibitors, undetectable by the Nijmegen assay, reduce factor VIII half‐life after immune tolerance inductionJournal of Thrombosis and Haemostasis, 2012
- Functional roles of the factor VIII B domainHaemophilia, 2009
- Inhibitors in factor IX deficiency a report of the ISTH‐SSC international FIX inhibitor registry (1997–2006)Haemophilia, 2009
- Quantitation of anti–factor VIII antibodies in human plasmaBlood, 2009
- Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia BBlood, 2001
- The Mode of Action of Antibodies which Destroy Factor VIII.British Journal of Haematology, 1972
- The Mode of Action of Antibodies which Destroy Factor VIII.British Journal of Haematology, 1972
- ACQUIRED INHIBITORS OF PLASMA FACTOR IX A STUDY OF THEIR INDUCTION, PROPERTIES AND NEUTRALIZATIONThe American Journal of the Medical Sciences, 1966